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Molecular evolution of Human 
Adenovirus (HAdV) species C
Akshay Dhingra1,6, Elias Hage1,6, Tina Ganzenmueller1,4,6, Sindy Böttcher2, Jörg Hofmann3, 
Klaus Hamprecht4, Patrick obermeier2,7,8, Barbara Rath7,8, Fabian Hausmann5, 
thomas Dobner5 & Albert Heim  1,6
Currently, 88 different Human Adenovirus (HAdV) types are grouped into seven HAdV species A to G. 
Most types (57) belong to species HAdV-D. Recombination between capsid genes (hexon, penton and 
fiber) is the main factor contributing to the diversity in species HAdV-D. Noteworthy, species HAdV-C 
contains so far only five types, although species HAdV-C is highly prevalent and clinically significant in 
immunosuppressed patients. Therefore, the evolution of species HAdV-C was studied by generating 
51 complete genome sequences from circulating strains. Clustering of the whole genome HAdV-C 
sequences confirmed classical typing results (fifteen HAdV-C1, thirty HAdV-C2, four HAdV-C5, two 
HAdV-C6). However, two HAdV-C2 strains had a novel penton base sequence and thus were re-labeled 
as the novel type HAdV-C89. Fiber and early gene region 3 (E3) sequences clustered always with the 
corresponding prototype sequence but clustering of the E4 region indicated recombination events in 26 
out of the 51 sequenced specimens. Recombination of the E1 gene region was detected in 16 circulating 
strains. As early gene region sequences are not considered in the type definition of HAdVs, evolution of 
HAdV-C remains on the subtype level. Nonetheless, recombination of the E1 and E4 gene regions may 
influence the virulence of HAdV-C strains.
Human adenoviruses (HAdVs) are double-stranded, non-enveloped, linear DNA viruses of 34–36 kbp length1,2. 
Currently, there are 88 different HAdV types known, which have been classified into seven species A to G and 
new adenovirus types continue to emerge1,3. Types were exclusively defined as serotypes (in cross-neutralization) 
up to type 51, for newer types a genotype definition was mostly used which requires either novel sequences or 
recombinant phylogeny in genes coding for major capsid proteins4.
The majority of HAdV types belong to species HAdV-D (57 types) followed by species HAdV-B (16 types) 
(http://hadvwg.gmu.edu/). Homologous recombination among capsid genes (hexon, penton and fibre) is imper-
ative in contributing to the high diversity of species HAdV-D types. In contrast, rapid selection of novel capsid 
gene sequences is the major factor for diversity in species HAdV-B1,3,5,6, although a few recombinant HAdV types 
of species B have also been described7. Recombination of capsid protein genes may diversify the tissue tropism of 
novel HAdV types and thus enhance the pathogenicity and virulence of the new viruses3,8,9.
Although infections with species HAdV-C types are highly prevalent, evolution of species HAdV-C did not 
results in multiple novel types, neither by recombination between the main capsid genes nor by rapid selection 
of e.g. immune escape mutations in the highly variable immunogenic loops of hexon. Despite species HAdV-C 
comprises only 5 types so far (1, 2, 5, 6 and 57), these are clinically more significant than species HAdV-B and 
-D in causing severe manifestations in immunocompromised patients, in particular in allogeneic hematopoietic 
stem cell transplant (HSCT) recipients10–12. More than half of adenovirus infections in immunocompromised 
hosts are associated with species C type 1 and 211–14. HAdV also accounts for 15% of upper respiratory tract infec-
tions and 5% of lower respiratory tract infections in adult and pediatric immunocompetent patients2,15. Species 
HAdV-C has been detected in the majority of respiratory tract infections followed by species B16,17. After primary 
infection, HAdV-C DNA can persist in a latent state in lymphoid cells and asymptomatic, intermittent shedding 
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of infectious virus in feces can be observed for many years10,18,19. Immunosuppression frequently leads to HAdV 
reactivation and severe clinical manifestations, such as disseminated adenoviral disease after HSCT2,8,19–21.
The high prevalence of infections with HAdV-C types in combination with the long-term latency of HAdV-C 
DNA should increase the probability of superinfection with another HADV-C type and thus promote the evolu-
tion of novel HAdV-C types by intertypic recombination. Still, only 5 types of HAdV-C have been described so 
far and little is known about the factors affecting pathogenicity and evolution of HAdV-C types and circulating 
HAdV-C strains. A recent study applying whole genomic sequencing to adenovirus specimens from immuno-
compromised pediatric patients confirmed the predominance of species HAdV-C strains in this population and 
detected an infection chain (transmission of HAdV-A31 between the included patients)22.
In the study presented here, 51 whole genome HAdV-C sequences were generated by next-generation 
sequencing of clinical isolates and diagnostic specimens and analyzed for recombinant phylogeny of genomes and 
diversity of immunogenic capsid proteins. Surprisingly, multiple recombination of early gene regions was found 
to be predominant in the evolution of these clinically relevant HAdV-C strains, whereas recombination of genes 
for major capsid proteins was almost absent and therefore only one novel type of species HAdV-C was found.
Results
Molecular typing by imputed serology. All specimens were initially typed by sequencing of loops 1 and 
2 of the main neutralization determinant ε. This molecular typing procedure gives the same results as the classi-
cal serological typing technique, neutralization testing, and thus is called “imputed serology”. 15 (out of the 51) 
specimens identified as type 1, 30 specimens as type 2, 4 specimens as type 5, 2 specimens as type 6 but none as 
type 57 (Table 1).
Nucleic acid sequences coding for the neutralization determinant of types HAdV-C1, -C2 and -C6 were highly 
conserved (identity 97.85–100% in loop1 and 97.89–100% in loop2, respectively), whereas these sequences were 
found to be more diverse in HAdV-C5 strains. In the latter, the loop 1 sequence identity was 96.20–99.12% and 
the loop 2 identity was 97.16–100% at the nucleotide level, at the amino acid level 97.38% – 98.44% and 97.22% 
to 98.76%, respectively (Fig. 1).
Molecular phylogeny of complete genomic sequences and major capsid proteins. Clustering of 
complete genomic sequences confirmed initial typing by imputed serology (Fig. 2).
In general, clustering of hexon and fiber gene sequences constantly followed clustering of complete genomic 
sequences, excluding intertypic recombination affecting hexon and fiber gene in the phylogeny of HAdV-C 
(Fig. 3).
Two strains (29C2 and 47C2) with a genomic backbone of type HAdV-C2 had a unique penton base sequence 
and presented as a novel cluster in the phylogenetic tree with a bootstrap value of 99% (Fig. 4). Compared to all 
other HAdV-C prototype sequences strains 29C2 and 47C2 had a unique substitution (A363E) and a unique dele-
tion of P364 in the hypervariable RGD loop of the penton base. This loop binds with its RGD amino acid motif 
to cellular integrins. Additionally, strains 29C2 and 47C2 had a L154Q substitution in the second hypervariable 
loop of the penton base compared to the species HAdV-C consensus sequence. Due to their unique penton base 
sequence, strains 29C2 and 47C2 were re-labelled as a novel HAdV-C type 89, with strain 29C2 as the prototype, 
designated as Adenovirus C human/DEU/Hannover/2015/89[P89H2F2]. Several amino acid substitutions were 
observed in the hypervariable region 1 (HVR1) and the hypervariable RGD loop which binds to the secondary 
cellular receptor in comparison to the other prototype sequences of HAdV-C (Fig. 5, for nucleotide sequences 
please see Supplementary Fig. S1).
Clustering of penton gene sequences suggested recombination of the penton base gene region in 9 genomes 
generated from other strains (9C2, 10C2, 23C2, 25C5, 26C2, 28C5, 31C2, 40C5, 49C5). Actually none of the 
analyzed 51 HAdV-C genomes had a penton sequence clustering with prototype 5. The only four type 5 strains 
(25C5, 28C5, 40C5, 49C5) found in this study were more closely related to type 6 regarding their penton sequence 
although this was not confirmed by high bootstrap values. Five HAdV type 2 strains (9C2, 10C2, 23C2, 26C2, 
31C2) had penton sequences clustering with type 1, but also without a significant bootstrap value. As a recombi-
nant phylogeny of the penton gene could not be confirmed by bootscanning, these 9 strains were not labelled as 
new genotypes. However, deduced amino acid sequences of the strains 9C2, 10C2, 23C2 and 26C2 were identical 
to type 1 and the deduced amino sequence of strain 31C2 had only a single amino acid substitution (Q377E) 
compared to the HAdV-C1 prototype sequence.
Molecular phylogeny of early gene regions. Multiple recombination events and novel sequence 
stretches were observed in the E1, E2 and E4 gene regions, whereas (with the single exception of strain 43C1) 
clustering of the E3 sequences was consistent with typing results in imputed serology and clustering of complete 
genomic sequences. The E3 sequence derived from strain 43C1 clustered with type 57 in the phylogenetic tree 
of the E3 region (Fig. S2). Although this clustering was not supported by a significant bootstrap value, a recom-
binant origin of strain 43C1 was indicated by bootscanning for the 5′ part of the E3 region (about nt. position 
27,500–29,000) (Fig. S3, 43C1). Bootscanning for the remaining part of the E3 gene region was not conclusive due 
to the closely related type 2 and type 57 prototype sequences, but multiple alignments of the deduced amino acid 
sequences of E3 gene products confirmed that strain 43C1 was closely related to these (or a common ancestor) 
but not to type HAdV-C1.
Surprisingly, five circulating strains (12C1, 20C1, 43C1, 45C6 and 46C6) clustered with type 57 in the E4 
gene region (supported by a 100% bootstrap value and confirmed by bootscanning), although circulation of 
HAdV-C57 was not observed in this study. E4 sequences of multiple type 1 and type 2 strains (4C1, 5C1, 9C2, 
10C2, 13C1, 18C1, 23C2, 26C2, 31C2, 32C1, 41C1, 50C1 and 51C1) clustered with type 5 (Fig. 6). This find-
ing was not supported by a significant bootstrap value, but bootscanning of these 13 sequences confirmed a 
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1C2 2000 2 Feces + 2 − MH121072
2C2 2000 2 Blood + 2 − MH121070
3C2 2002 2 Blood + 2 − MH121071
4C1 2002 1 Urine + 1 − MH121073
5C1 2002 1 Blood + 1 − MH121074
6C1 2008 1 Blood + 1 − MH121075
7C1 2008 1 Feces + 1 − MH121076
8C2 2009 2 URT − 2 − MH121077
9C2 2009 2 URT − 2 − MH121078
10C2 2010 2 URT − 2 − MH121079
11C2 2012 2 LRT − 2 − MH121080
12C1 2012 1 URT − 1 − MH121081
13C1 2012 1 Feces + 1 − MH121082
14C2 2012 2 Feces + 2 − MH121083
15C2 2012 2 Blood + 2 − MH121084
16C2 2012 2 Feces − 2 − MH121085
17C2 2013 2 LRT − 2 − MH121086
18C1 2013 1 Feces + 1 − MH121087
19C2 2013 2 Blood + 2 − MH121088
20C1 2013 1 Blood + 1 − MH121089
21C2 2014 2 Blood + 2 − MH121090
22C1 2014 1 URT − 1 − MH121091
23C2 2014 2 Blood + 2 − MH121092
24C2 2014 2 Blood + 2 − MH121093
25C5 2014 5 Feces + 5 − MH121094
26C2 2014 2 Feces + 2 − MH121095
27C2 2015 2 URT − 2 − MH121096
28C5 2015 5 Feces + 5 − MF681662
29C2 2015 2 Feces + 2 89 MH121097
30C1 2015 1 Feces + 1 − MH121098
31C2 2015 2 URT − 2 − MH121099
32C1 2015 1 URT − 1 − MH121100
33C2 2015 2 Feces + 2 − MH121101
34C2 2015 2 Feces + 2 − MH121102
35C2 2015 2 Blood + 2 − MH121103
36C2 2015 2 Feces + 2 − MH121104
37C2 2015 2 Feces + 2 − MH121105
38C2 2016 2 Feces + 2 − MH121106
39C2 2016 2 Blood + 2 − MH121107
40C5 2015 5 Feces + 5 − MH121118
41C1 2016 1 Feces + 1 − MH121108
42C2 2017 2 Feces + 2 − MH121109
43C1 2017 1 Feces + 1 − MH121110
44C2 2017 2 Feces + 2 − MH121111
45C6 2017 6 Feces + 6 − MH121112
46C6 2017 6 Feces + 6 − MH121113
47C2 2017 2 Feces + 2 89 MH121114
48C2 2017 2 Feces + 2 − MH121115
49C5 2017 5 Feces + 5 − MH121119
50C1 2017 1 Feces + 1 − MH121116
51C1 2017 1 URT − 1 − MH121117
Table 1. Origin and characteristics of species HAdV-C strains analyzed in this study (URT: upper respiratory 
tract, LRT: lower respiratory tract).
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recombinant origin of the E4 sequence. Moreover, these isolates had deduced amino acid sequences identical to 
the sequence of prototype HAdV-C5 in E4ORF3, E4ORF4 and E4ORF6/7. Five other type 2 strains (3C2, 29C2, 
33C2, 34C2, 47C2) were more distantly related to the HAdV-C5 prototype sequence, but the recombinant origin 
of these E4 sequences was also confirmed by bootscanning only. E4ORF3 and E4ORF4 deduced amino sequences 
of 3C2, 29C2, 33C2, 34C2, 47C2 were also identical to the HAdV-C5 prototype sequence but E4OR6/7 was not. 
Vice versa, three type 5 strains (25C5, 28C5 and 49C5) clustered with type 1 in the E4 region. Although the boot-
strap value of this cluster was not significant, probably due to the very low sequence diversity between prototype 1 
and prototype 2 E4 sequences, recombination was confirmed by bootscanning. Finally, three type 1 strains (6C1, 
7C1 and 30C1) clustered with type 2 in the E4 region with a 92% bootstrap probability but recombination of the 
E4 region was not supported by bootscanning.
As gene products of E4 and E1 interact with each other, similar clustering of strains in the E1 phylogenetic 
tree as observed in the E4 phylogenetic tree was anticipated. Surprisingly, phylogenetic analyses of the E1 region 
showed a completely different clustering (Fig. 6).
Only a single sequence (strain 40C5) clustered with prototype HAdV-C5 in the E4 region and in E1 region. 
Three type 2 strains (9C2, 26C2, 31C2) clustered with prototype HAdV-C1 in the E1 region (supported by a 
100% bootstrap value and confirmed by bootscanning) indicating an E1 sequence of recombinant origin. There 
were 13 other type 2 strains (1C2, 2C2, 8C2, 14C2, 15C2, 19C2, 21C2, 35C2, 36C2, 37C2, 38C2, 39C2 and 48C2) 
Figure 1. Phylogenetic analysis of the nucleic acid sequences of the neutralization ε determinant loop 1 (A) 
and loop 2 (B) of the hexon. Genbank sequences of the five HAdV-C prototypes are highlighted by a black dot 
(labelling indicates accession number-species and type). The neighbor-joining tree was generated based on the 
Kimura two-parameter model with MEGA7. Bootstrap values < 80% are not robust and therefore not depicted. 
*Strains 29C2 and 47C2 were renamed as the novel type HAdV-C89.
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and one type 5 strain (49C5) that also clustered with type HAdV-C1 prototype sequence in the E1 gene region. 
Recombination was confirmed by bootscanning, but clustering in the tree was non-significant (low bootstrap 
value). Surprisingly, one strain (40C5) had an intra-E1 recombination event in its phylogeny indicated by boots-
can analysis with the E1A region closely related to prototype HAdV-C1 and the E1B region (and most of its 
genomic backbone) closely related to HAdV-C5 (Fig. S3).
Figure 2. Phylogenetic analysis of whole-genome sequences. Clustering of nucleic acid sequences of circulating 
strains with Genbank sequences of the five species HAdV-C prototypes (highlighted by a black dot, labelling 
indicates accession number-species and type). The neighbor-joining tree was generated based on the Kimura 
two-parameter model with MEGA7. Bootstrap values < 80% are not robust and therefore not depicted. *Strains 
29C2 and 47C2 were renamed as the novel type HAdV-C89.
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In the E2A region five type 2 isolates (9C2, 10C2, 23C2, 26C2, 31C2) and one type 6 strain (45C6) were found 
to have a recombinant phylogeny and clustering with the prototype HAdV-C1 (supported by significant bootstrap 
values) (Fig. S4). Moreover, the two isolates representing the novel prototype HAdV-C89 (29C2 and 47C2) had a 
unique E2A sequence compared to all other isolates and prototypes.
Genes of the E2B region (encoding e.g. the DNA polymerase) are highly conserved between all HAdV-C pro-
totypes and circulating strains analyzed in this study with the exception of strains 43C1 and 50C1. These clustered 
on their own and had unique amino acid substitutions in comparison with all other isolates in the deduced amino 
acid sequence (Fig. S4).
Molecular phylogeny of minor capsid proteins. Sequence diversity of all six minor capsid proteins 
(IIIa, V, VI, VII, VIII, and IX) was very low and a recombinant phylogeny could not be detected. Interestingly, 
two circulating type 2 strains (33C2 and 34C2, derived from the same patient) had a deletion of three amino acids 
(position 447 to 449) as compared to the prototype HAdV-C2 sequence in the IIIa protein (data not shown). 
In the minor capsid protein V a deletion of two amino acids (serine and threonine at 228–229 aa position) was 
detected in two other circulating strains (1C2 and 2C2).
Minor capsid proteins VII and VIII were highly conserved at the nucleotide and amino acid level. In the 
amino acid alignment of minor capsid protein IX, 11 out of the 30 type 2 isolates (1C2, 2C2, 8C2, 9C2, 14C2, 
Figure 3. Phylogenetic analysis of the major capsid genes hexon (A) and fiber (B). Clustering of circulating 
strains and Genbank sequences of HAdV-C prototypes (highlighted by a black dot, labelling indicates accession 
number-species and type). The neighbor-joining tree was generated based on the Kimura two-parameter model 
with MEGA7. Bootstrap values < 80% are not robust and therefore not depicted. *Strains 29C2 and 47C2 were 
renamed as the novel type HAdV-C89.
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15C2, 19C2, 21C2, 26C2, 31C2, 42C2) were found to be more similar to prototype HAdV-C1 as they contain two 
amino acid substitutions (A3T and D123E) as compared to prototype HAdV-C2 protein IX amino acid sequence.
Discussion
In the present study, analysis of the complete genomes of 51 circulating species HAdV-C strains revealed mul-
tiple recombination events of early gene regions (e.g. E1 and E4) that may contribute to the evolution of species 
HAdV-C. To our knowledge this has never been described before.
The E4 region encodes for six proteins (ORF1, ORF2, ORF3, ORF4, ORF6 34 K and ORF6/7), which are 
known to have one or more function required for lytic growth of virus, transcription of viral genes and repli-
cation23–25. E4 sequences of the HAdV-C1 and -C2 prototypes and many of the analyzed type 1 and 2 circulat-
ing strains were highly conserved; therefore conclusions on recombination between these two types were not 
feasible. In spite of this, 21 out of 45 analyzed type 1 and 2 strains displayed a recombinant E4 region. Five 
of these 21 strains clustered with HAdV-C57 in the E4 region and 14 of these strains had HAdV-C5 like E4 
Figure 4. Phylogenetic analysis of the major capsid gene penton base. Clustering of circulating strains and 
prototype sequences (highlighted by a black dot, labelling indicates accession number-species and type). Strains 
29C2 and 47C2 were highlighted with a blue box and renamed as novel type HAdV-C89. The neighbor-joining 
tree was generated based on the Kimura two-parameter model with MEGA7. Bootstrap values < 80% are not 
robust and therefore not depicted.
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sequences, although this was confirmed by bootscanning only. Therefore, HAdV-C5 like and HAdV-C57 like E4 
sequences were highly “overrepresented” in the analyzed circulating virus strains compared to their typing results 
in imputed serology and their genomic backbone. This indicated a positive selection for these recombinant type 
1 and 2 strains that have an E4 region sequence of type 5 or 57. This positive selection was observed both in the 
39 analyzed strains originating from immunosuppressed patients, where these can cause severe disseminated 
infections with high virus loads in peripheral blood (as e.g. strain 40C526) and in the 12 other analyzed strains 
originating from usually mild respiratory infections of immunocompetent patients.
Although the sequence diversity between type 5 and types 1 and 2 is low in the E4 gene region, type 5 has 
substantial amino acid substitutions in its E4 ORFs compared to types 1 and 2. Prototypes of HAdV-C1, -C2, 
-C6 and many of the analyzed circulating strains shared an identical amino acid E4ORF4 sequence but prototype 
HAdV-C5 had a distinctive substitution of serine at position 67 that was also present in seventeen circulating 
strains clustering with prototype 5 in the E4 gene region. The novel prototype HAdV-C89 strains (29C2 and 
47C2) also cluster with the HAdV-C5 sequence, but have three other amino acid substitutions which may affect 
the binding of E4ORF4 to PP2A, a key function for this E4 protein27–30.
The deduced amino acid sequences of the E4ORF6/7 region of prototypes HAdV-C2, -C6, -C57 and many 
circulating HAdV-C strains were identical. However, prototype HAdV-C5 and 13 circulating strains (4C1, 5C1, 
9C2, 10C2, 13C1, 18C1, 23C2, 26C2, 31C2, 32C1, 41C1, 50C1 and 51C1) have a distinctive K at position 68 which 
might serve as a SUMO2/3 acceptor site in the E4orf6/7 protein, thus affecting promoter activation by E4orf6/7 
or its stability (Melling, personal communication).
Moreover, the deduced amino acid sequence of the E4ORF331,32 is identical in prototypes HAdV-C1, -C2, -C6 
and -C57, but the prototype of HAdV-C5 has one substitution L33R that was conserved in all circulating recom-
binant HAdV-C strains clustering with this prototype’s E4 region sequence.
The E4ORF1 gene product binds via its C-terminal PDZ binding motif (S/T-X-¥) to proteins containing PDZ 
domains and as expected this motif was highly conserved in all our E4ORF1 sequences33,34. With exception of 
the C-terminal region, multiple amino acid substitutions and deletions were observed in circulating strains like 
41C1 and 1C2, but will probably not affect the function of this motif. Interestingly, these mutations were only 
observed in the circulating virus strains whereas in all species HAdV-C prototypes the complete E4ORF1 amino 
acid sequence is conserved.
The overall genetic diversity of the E1 region was higher than in the E4 region and also many (17 out of 51) 
circulating HAdV-C strains were found to be recombinant in the E1 region (confirmed by bootscan analysis 
although only three of these strains clustered with significant bootstrap value). As E1 and E4 proteins interact 
with each other, a similar clustering of strains in the E1 region as in the E4 region could be expected, but surpris-
ingly almost all circulating strains except 49C5 clustered differently in these phylogenetic trees. The E1 region 
encodes only three functional proteins (E1A, E1B-19K and E1B-55K). E1A has a conserved region 4 (CR4) at 
amino acid position 202–210 which mediates interactions with host cell proteins such as the corepressor CtBP35. 
Figure 5. Multiple amino acid alignments of the hypervariable loops of the penton base. (A) RGD loop 
sequences and (B) hypervariable region 1 sequences of all HAdV-C prototypes including the novel HAdV-C89.
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Three circulating strains (43C1, 45C6, 46C6) had few substitutions in the CR4 region that might affect the interac-
tion with host cell proteins36. Four strains (9C2, 26C2, 31C2 and 41C1) had a P140S substitution in the E1B-19K 
sequence which may affect the Bcl-2- homology region 2 (BH2) known to inhibit apoptosis by the E1B protein37. 
Apart from this single substitution the E1B-19K amino acid sequence was observed to be highly conserved. The 
N-terminal region of large E1B-55k protein represents an intrinsically disordered protein domain38 and corre-
spondingly the sequence of this region was less conserved than the C-terminal region in the circulating strains.
The E3 region contains seven genes affecting the host immunity after virus infection but not essential for the 
replication of HAdV-C39. In our study, the E3 gene region sequences of circulating strains were highly conserved 
and clustered with their respective prototype sequence, with the exception of strain 43C1. This recombination is 
clearly evident because the E3 sequences of different HAdV-C prototypes are highly divergent. The type 1 strain 
43C1 clustered with the prototype HAdV-C57 E3 region sequence (Fig. S2) and thus is the only candidate to study 
further the effects of a recombinant E3 region in species HAdV-C. With this single exception, clustering suggested 
coevolution of the E3 region with the major capsid proteins hexon and fiber in species HAdV-C, whereas in species 
HAdV-D, homologous recombination in the E3 region (specifically CR1 genes) has been confirmed previously40.
Figure 6. Phylogenetic analysis of the early gene regions E1 (A) and E4 (B). Clustering of circulating strains 
and prototype sequences (highlighted by a black dot, labelling indicates accession number-species and type). 
The neighbor-joining tree was generated based on the Kimura two-parameter model with MEGA7. Bootstrap 
values < 80% are not robust and therefore not depicted. *Strains 29C2 and 47C2 were renamed as the novel type 
HAdV-C89.
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Recombination events between the genes encoding major capsid proteins (hexon, fiber and penton) are an 
important mechanism in the evolution of species HAdV-D types, but almost absent in the evolution of species 
HAdV-C strains as confirmed by our sequence data1,5,40. Conserved sequence segments (called “universal con-
served segments”) are present in HAdV-D genomes, e.g. in the penton base gene, the hexon gene and multiple 
ones in the E3, fiber and E4 genes, that drive the recombination of these regions41,42. Obviously, this mechanism 
is absent in species HAdV-C. Therefore, recombination of genes encoding major capsid proteins seems to be 
almost impossible in species HAdV-C, as also observed in the present study. The single exception to this rule 
of non-recombinant evolution of major capsid proteins in species HAdV-C is type HAdV-C57. Its penton base 
sequence is closely related to type HAdV-C1, its fiber to type HAdV-C6 and it has a unique hexon sequence and 
thus a novel neutralization determinant sequence14. Surprisingly, all circulating strains had neutralization epitope 
sequences identical (or almost identical) to the prototype sequences (Fig. 1) although a rapid evolution of these 
loop 1 and 2 sequences could be driven by an immune escape mechanism. This was previously described in spe-
cies HAdV-B1,3,5,6 but was obviously absent in species HAdV-C. Perhaps, E3 gene products interfering with the 
immune-response against HAdV-C type infected cells39,43,44 could be so effective that there was almost no positive 
selection of immune escape mutations.
In this study, another novel prototype of species HAdV-C has been described (type 89). It was typed ini-
tially as a HAdV-C2 strain by conventional methods, because both hexon and fiber sequences, as well as most 
of its genetic backbone are closely related to the HAdV-C2 prototype sequence. However, HAdV-C89 was found 
to have a novel penton base sequence. In general, penton base sequences of species HAdV-C types are far less 
diverse as in species HAdV-D, but interestingly the novel type HAdV-C89 penton base sequence is most diverse 
compared to the old prototypes in the functional RGD loop. Although amino acid residues adjacent to the RGD 
motif were conserved (Fig. 5), the conformation of the RGD site may be different and thus, binding properties 
of type 89 to the secondary cellular receptor compared to other HAdV-C types45,46. Moreover, HAdV-C89 has a 
recombinant E4 region (Fig. 6) closely related to HAdV-C5 suggesting a recombinant phylogeny of this region, 
which may also influence its virulence. On the other hand, prevalence of type 89 in the present study was low, 
representing only two out of 51 strains. These were isolated from different patients, strain 29C2 in 2015 and strain 
47C2 in 2017, respectively. Prevalence of HAdV-C89 strains in this study was about equal to HAdV-C6 but, for 
comparison, not a single strain of HAdV-C57 was detected in the present study.
In conclusion, simple typing procedures, as merely a partial sequencing of the hexon gene of a diagnostic 
specimen, seem to be sufficient to describe the “core region” of the HAdV-C genome. This includes the hexon and 
the fibre gene and the E3 region, which was considered to be important for immune escape and probably long 
term persistence of HAdV-C strains after primary infection. On the other hand, these routine typing strategies 
will not detect novel penton base sequences and thus would have missed the novel type 89. Moreover, future 
studies employing complete genomic sequencing on circulating HAdV-C strains are needed to study the clinical 
significance of recombination in the E1 and E4 regions as e.g. the predominance of type 5 derived E4 regions in 
the present study.
Methods
Specimens and strains. A total of 51 species HAdV-C strains were obtained between the years 2000 and 
2017 from clinical specimens originating from the upper respiratory tract (URT, n = 9), lower respiratory tract 
(LRT, n = 2), feces (n = 27), blood (n = 12) and urine (n = 1). For 11 of these specimens adenoviruses were iso-
lated on A549 cell cultures prior to sequencing, direct sequencing was applied to the other specimens (Table 1). 
Specimens originated from 40 patients; strains 6C1, 7C1 and 30C1 originated from a single patient as did strains 
35C2, 36 C2, 37C2, 38 C2 and 39C2 from another patient. Strains 1C2 and 2C2 also originated from a single 
patient, as did strains 4C1 and 5C1, 14C2 and 15 C2, 33 C2 and 34 C2, 45C6 and 46C6. Specimens originated 
from different regions of Germany. Table 1 shows an overview of specimens sequenced, year of isolation and 
Genbank Accession Number.
Nucleic acid extraction and viral load quantitation. Extraction of DNA from 200 µl clinical mate-
rial or cell culture supernatant was performed as described by QIAamp DNA Blood Mini Kit (Qiagen, Hilden, 
Germany). HAdV DNA was quantified by a generic, quantitative real-time PCR as described previously47.
Imputed serology by partial sequencing. Initial typing was performed by Sanger sequencing of parts of 
the neutralization epitope (loop 1 and loop 2) of the hexon gene (imputed serology) and the fibre knob gene as 
previously described48.
Enrichment of HAdV DNA and library preparation. Library preparation of 42 specimens (including 
all cell culture isolates) with sufficient HAdV DNA load (a ratio of HAdV/human genomic DNA >1,000) was 
performed using Nextera XT DNA library preparation kit (Illumina, San Diego, CA, USA) with 1 ng of DNA as 
input following manufacturers’ guideline. Purified DNA of the other nine specimens (6C1, 19C2, 20C1, 23C2, 
24C2, 35C2, 47C2, 48C2 and 50C1) was sheared by sonication, and sequencing libraries were prepared directly 
(KAPA library preparation kit, KAPA Biosystems, Wilmington, MA, USA) as previously described49, with a 
few modifications. DNA fragments were end-repaired, A-tailed and ligated to NEBnext Illumina adapter (New 
England Biolabs, Ipswich, MA, USA). After PCR pre-amplification (6–14 cycles) with adapter specific primers, 
up to 750 ng of DNA was target enriched for HAdV fragments with RNA baits. These 120-mer RNA baits were 
designed to span the length of the positive strand of 24 Genbank HAdV-C1, -C2 and -C5 reference genomes 
(SureSelectXT kit, Agilent Technologies, CA, USA).
Next generation sequencing and bioinformatics. After quality control, libraries were sequenced on 
an Illumina MiSeq platform (2*300 bp paired-ends run, v3 sequencing chemistry). The obtained sequence data 
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was quality controlled and de novo assembled using CLC Genomics Workbench v9 (Qiagen, https://www.qiagen-
bioinformatics.com/products/clc-genomics-workbench/ and SPAdes v3.650 with minimum average coverage of 
22 and maximum average coverage 78111 per nucleotide. Genome annotations were transferred from the most 
closely related type and cross-checked by using an ORF finder followed by BLAST analysis using Geneious v10 
(https://www.geneious.com/).
Phylogenetic and recombination analysis. A multiple alignment of whole genomic sequences was 
constructed using fast Fourier transforms (MAFFT)51. This software (https://www.ebi.ac.uk/Tools/msa/mafft/) 
was applied using the default gap parameters. Pairwise alignment, comparisons and visualization of genomes 
were performed on BioEdit version 7.2.0 (http://www.mbio.ncsu.edu/BioEdit/page2.html). Bootstrapped, 
neighbor-joining (Kimura 2-parameter model) phylogenetic trees with 1000 replicates were constructed using 
MEGA v7 software. Similarity plots and recombination detection (bootscan approach) was performed using 
Simplot software (version 3.5.1) with a window size of 1000 bp and step size of 200bp52. The following com-
plete genomic nucleotide sequences representing all prototypes of the HAdV-C species were used in the anal-
ysis (Genbank accession numbers in parentheses): HAdV-C1 (AC000017), HAdV-C2 (AC000007), HAdV-C5 
(AC000008), HAdV-C6 (FJ349096) and HAdV-C57 (HQ003817). Furthermore, amino acid alignments for each 
gene were constructed with ClustalW program.
Ethical statement. All methods were carried out in accordance with relevant guidelines and regulations. 
For scientific use of routine anonymized data, ethical approval is not required in Germany (confirmed by a letter 
of the local ethical committee “Ethikkommission der Medizinischen Hochschule Hannover”, 9th of April, 2018). 
This study analyzed molecular phylogeny of the species human adenovirus C and did not include experimenta-
tion with human tissue, therefore informed consent of patients is not required for this type of study.
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